Driving innovation in respiratory health: Areteia’s 2025 milestones and future goals
During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a detailed review of its achievements in 2024 and outlining its 2025 plans. Led by CEO Jorge Bartolome, the company highlighted its …